1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TBC1D26 CTRPv2 pan-cancer AAC 0.14 8e-06
mRNA ZBED3 CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA POU2F1 CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA SUZ12 CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA CHAF1A CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA APPL1 CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA SRSF12 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA ASPH CTRPv2 pan-cancer AAC -0.16 9e-06
mRNA ATAD5 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA OSGIN1 CTRPv2 pan-cancer AAC -0.15 9e-06
Download CSV